NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-64 Cr |
| Mar2024 | ₹-121 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-36 Cr |
| Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-64 Cr | Negative | |
| Mar2024 | ₹-121 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-36 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹1,975.8 Cr | 2.2% | 3.3% | -5.9% | Stock Analytics | |
| ADANI ENTERPRISES | ₹276,279.0 Cr | -1.6% | -4.3% | -6.6% | Stock Analytics | |
| REDINGTON | ₹20,607.6 Cr | -2.1% | -3.7% | 30.3% | Stock Analytics | |
| MMTC | ₹10,296.0 Cr | 8.2% | 27.1% | -0.1% | Stock Analytics | |
| HONASA CONSUMER | ₹9,238.9 Cr | -1.1% | 10.3% | 17.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,588.4 Cr | -7.9% | -11.5% | 18.8% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 2.2% |
3.3% |
-5.9% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses